MicroRNAs (miRNAs) are small noncoding RNAs which mediate some of the pathological mechanisms of diabetic retinopathy. The aim of this study was to identify differentially expressed miRNAs in the vitreal exosomes of proliferative diabetic retinopathy (PDR) patients and non-diabetic controls. Exosomes were extracted from the vitreous samples of 10 PDR patients and 10 controls. The expression of 372 miRNAs was determined using a quantitative polymerase chain reaction (qPCR) panel. We have demonstrated a significant dysregulation in 26 miRNAs. The most remarkable findings include a profound attenuation of the miR-125 family, as well as enhanced miR-21-5p expression in the diabetic samples. We also showed the downregulation of miR-204-5p and th...
Diabetic retinopathy (DR) is a major cause of vision reduction in diabetic patients. Hyperglycemia i...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
<div><p>MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by post-transcript...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
The main objective of this pilot study was to identify circulatory microRNAs in aqueous or plasma th...
Background and Purpose: Diabetic retinopathy, a secondary complication of diabetes mellitus, can lea...
Abstract Exosomes are small extracellular vesicles 40–160 nm in diameter that are secreted by almost...
Background and Purpose: Diabetic retinopathy, a secondary complication of diabetes mellitus, can lea...
Objectives Diabetic macular edema (DME) is a complication of diabetes mellitus that leads to diabeti...
In this study we analyzed the expression of circulating miRNAs, in the serum of diabetic retinopathy...
In this study we analyzed the expression of circulating miRNAs, in the serum of diabetic retinopathy...
Diabetic retinopathy (DR) is the leading cause of vision loss in the working-age adults. It affects ...
Diabetic retinopathy (DR) is a major cause of vision reduction in diabetic patients. Hyperglycemia i...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
<div><p>MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by post-transcript...
Purpose: microRNAs (miRNAs) mediate the pathological mechanisms of diabetic retinopathy. In this stu...
The main objective of this pilot study was to identify circulatory microRNAs in aqueous or plasma th...
Background and Purpose: Diabetic retinopathy, a secondary complication of diabetes mellitus, can lea...
Abstract Exosomes are small extracellular vesicles 40–160 nm in diameter that are secreted by almost...
Background and Purpose: Diabetic retinopathy, a secondary complication of diabetes mellitus, can lea...
Objectives Diabetic macular edema (DME) is a complication of diabetes mellitus that leads to diabeti...
In this study we analyzed the expression of circulating miRNAs, in the serum of diabetic retinopathy...
In this study we analyzed the expression of circulating miRNAs, in the serum of diabetic retinopathy...
Diabetic retinopathy (DR) is the leading cause of vision loss in the working-age adults. It affects ...
Diabetic retinopathy (DR) is a major cause of vision reduction in diabetic patients. Hyperglycemia i...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of ...